5 Must-Watch ETF Charts of Q2 Earnings

Published 08/26/2021, 11:10 PM
Updated 10/23/2024, 11:45 AM
PFE
-

The Q2 earnings picture is very strong, with broad-based strength across all major sectors and the overall quarterly total on track to reach a new record. Total Q2 earnings from 466 S&P 500 members or 93.9% of the index’s total membership are up 97.8% from the same period last year on 25.8% higher revenues, with 86.9% beating EPS and 86.9% surpassing revenue estimates.

Earnings and revenue growth as well as beat ratios are tracking above the recent historical period. Additionally, earnings estimates have been on a rise for the current quarter and beyond.

Given this, several equity ETFs have impressed with their performance and generated handsome returns over the trailing one-month period though surge in COVID-19 cases with the spread of the Delta variant has suppressed the returns somewhat. Below are five ETFs that have gained from strong earnings results. In addition, we have given a chart for their one-month performance and compared them with the broad market fund SPY and the broad sector.

ETFMG Treatments Testing and Advancements ETF GERM

This fund offers exposure to biotech companies directly engaged in the testing and treatments of infectious diseases. It has risen 11.7% in a month driven by strong Q2 earnings growth and Pfizer (NYSE:PFE) vaccine approval news. Earnings for 95.4% of the healthcare sector are up 30.2% from the same period last year on 21.1% higher revenues, with 88.5% of the companies beating on EPS and 96.2% topping revenue estimates (read: Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs).

Zacks Investment Research
Image Source: Zacks Investment Research

Global X Cybersecurity ETF BUG

This ETF offers exposure to the companies that stand to benefit from the increased adoption of cybersecurity technology. Total Q2 earnings for 87.6% of the technology sector are up 65.7% from the same period last year on 25.7% higher revenues, with 96.8% of the companies beating on EPS and 93.7% surpassing revenue estimates. The combined beat is 92.1% — the second highest this earnings season. As such, BUG from cybersecurity corner emerged as the biggest winner, gaining 7.6% in a month.

Zacks Investment Research
Image Source: Zacks Investment Research

iShares U.S. Broker-Dealers & Securities Exchanges ETF IAI

With 100% of the results out, the financial sector’s Q2 earnings rose 146.5% on revenue growth of 10.8%. The earnings growth rate is the fourth highest of all the sectors and the only pure-play broker dealer ETF is the winner. IAI offers exposure to U.S. investment banks, discount brokerages, and stock exchanges. It has returned 6.5% over the past month and carries a Zacks ETF Rank #2 (Buy) with a High risk outlook (read: 5 Financial ETFs to Buy on Taper Talks).

Zacks Investment Research
Image Source: Zacks Investment Research

First Trust Nasdaq Retail ETF FTXD

The fund offers exposure to U.S. companies within the retail industry. Earnings for 93.8% of the retail sector that have reported Q2 results are up 44.6% on revenue growth of 14.3%, with 91.7% beating on EPS and 95.8% surpassing top-line estimates. This is a much stronger showing from the retailers than what we have seen from the group in other recent periods. As a result, FTXD was up 4.2% over the past month and carries a Zacks ETF Rank #3 (Hold) (read: Retail ETFs Mixed on Blockbuster Q2 Earnings Wave).

Zacks Investment Research
Image Source: Zacks Investment Research

Invesco S&P 500 Equal Weight Materials ETF RTM

This fund provides equal-weight exposure to the stocks in the materials sector. Total earnings for the basic materials sector are up 277.4% on 47.3% higher revenues. Earnings growth represents the highest and revenues take the fourth highest spot. Given this, RTM has gained 4.1% in the past month and carries a Zacks ETF Rank #2 with a Medium risk outlook.

Zacks Investment Research
Image Source: Zacks Investment Research


5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SPDR S&P 500 ETF (SPY): ETF Research Reports

iShares U.S. BrokerDealers & Securities Exchanges ETF (IAI): ETF Research Reports

First Trust NASDAQ Retail ETF (FTXD): ETF Research Reports

Invesco S&P 500 Equal Weight Materials ETF (RTM): ETF Research Reports

GLBLX CYBRSEC (BUG): ETF Research Reports

ETFMG Treatments, Testing and Advancements ETF (GERM): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.